With HydRegen, I was immediately struck not only by the energy and ambition of the team, but also by the potential HydRegen technology has to make a real impact in the pharmaceutical sector and many others. Their innovative biocatalysis technology provides an efficient and sustainable alternative to traditional chemical manufacturing processes, and they have already started to demonstrate real world applications and impact.

HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of Piera De Santis as a Scientist of Molecular Biology. Following more than 3 years studying for her double doctorate degree in biological and chemical engineering, and organic chemistry, Piera has extensive experience in bioprocess engineering, enzyme manipulation, organic chemistry and analytical analysis.

HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of John Boyle as a Scientist of Organic Chemistry. With more than 4 years’ experience in chemical biology and organic chemistry, John brings extensive knowledge of microbial biotransformation and recombinant enzymes.

HydRegen successfully completes tech transfer to Almac Sciences as part of the joint development project of its proprietary enzyme platform.

HydRegen and researchers from the University of Nottingham’s Faculty of Engineering collaborate in a project to unlock sustainable biocatalytic hydrogenation and receive grant funding from BBSRC, EPSRC and IUK to complete the feasibility study.

By joining a smaller company, I was able to gain exposure to many different parts of the business and get involved in a broad range of activities. As well as working in the laboratory, I was helping with grant applications, writing content and implementing social media activities. Of course, the laboratory work was the biggest part of my placement, but it was a great experience getting involved in other elements that opened my eyes to what is really involved in running a successful business.

HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of Dr Willem Breukelaar as a Scientist and specialist in biocatalysis. Following more than 4 years of specialist research, Willem brings a broad knowledge of biocatalytic reactions in organic chemistry and enzyme production.

HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of Rhiannon Evans as Head of Enzyme Production and Molecular Biology, leading its enzyme production, optimisation and efficiency development projects. Rhiannon brings extensive experience of enzyme purification, handling and reaction mechanisms from over 15 years of research exploring enzyme optimisation in different environments.

HydRegen, the revolutionary bioscience company, is proud to announce the appointment of Giovanni Davide Barone as Molecular Biology Specialist, to expand their capabilities in metal-containing enzyme production and increase manufacturing readiness of their lead product. Giovanni brings a deep understanding of industrial biotechnology and biocatalysis from his extensive research of molecular biology and metabolic engineering.

HydRegen welcomes Matt Hodges to the team as Commercial and Operational Lead!

Following their attendance at the recent NextGenBiocat symposium, HydRegen’s Chief Scientific Officer, Sarah Cleary, and Product Development Specialist, Jack Allman, share their thoughts on some of the key takeaways and highlights from the event.

HydRegen are proud to announce co-founder and CEO, Dr Holly Reeve, has received the 2022 RSC Felix Franks Biotechnology Medal for her contributions to chemical biotechnology.

HydRegen, the revolutionary bioscience company, have appointed Miguel Ramirez Hernandez as Head of Molecular Biology and Enzyme Production. Miguel will bring a whole new area of R&D and expertise to the team at HydRegen, enabling them to compete with peers in the industrial biotechnology sector and expanding their competencies.

HydRegen secures funding round led by UKI2S and partners with Almac for joint technology development for sustainable chemical manufacturing

Earlier this month I was listed as one of the 30 most talented trendsetters who are tackling the biggest health challenges of our time, in the ninth BioBeat Movers & Shakers in BioBusiness Report for 2021. Our system, that decarbonises biocatalytic processes and replaces toxic metal catalysts, was highlighted as one of the revolutionary bioscience products for healthcare, transforming the production of drugs and speciality chemicals.